Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R. Chappidi, Trinity J. Bivalacqua, Max Kates et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 130
Understanding and targeting the Rho kinase pathway in erectile dysfunctionNikolai A. Sopko, Trinity J. Bivalacqua, Johanna L. Hannan|Nature Reviews Urology|2014Cited by 84
Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder CancerMax Kates, Trinity J. Bivalacqua, Thomas R. Nirschl et al.|Cancer Immunology Research|2017Cited by 77
Pathophysiology of Erectile DysfunctionHotaka Matsui, Trinity J. Bivalacqua, Nikolai A. Sopko et al.|Current Drug Targets|2015Cited by 73
Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder CancerMax Kates, Trinity J. Bivalacqua, Taarika Babu et al.|Clinical Cancer Research|2017Cited by 64